Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T18:22:32.631Z.
Calculation as of: 2026-10-06T18:22:32.631Z.
Quote observation: 2026-10-06T18:13:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f8447282adf6e47d1ec21ed7020f0f216562717f012d53baf90ed137265b4b00
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Market Cap
$1.83M
PB Ratio
N/A
TTM Avg
3.65
3Y Avg
51.61
5Y Avg
304.73
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.88M | N/A | N/A | N/A | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.89M | N/A | 1.76 | 1.62 | 2.55 |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | 2.78 | 2.95 | 2.42 | 3.23 |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | N/A | 3.17 | 2.55 | 2.42 |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.83M | N/A | 3.65 | 51.61 | 304.73 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | 0.61 | 0.56 | 1.01 | 1.01 |
| Silo Pharma, Inc. (SILO)vs › | $1.63M | 0.33 | 0.74 | 0.74 | 0.99 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.17M | 1.23 | 2.12 | 10.33 | 7.40 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.17M | N/A | 6.72 | 29.68 | 20.79 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.48M | 0.34 | 0.64 | 0.64 | 0.64 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
